Page last updated: 2024-09-04

carbapenems and Pneumonia

carbapenems has been researched along with Pneumonia in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.28)	18.2507
2000's	4 (6.56)	29.6817
2010's	33 (54.10)	24.3611
2020's	22 (36.07)	2.80

Authors

Authors	Studies
Almeida Amaral, F; Boff, D; César Moreira Brito, J; Cristina Sampaio de Assis, D; Elena de Lima, M; Gustavo Lima, W; Magalhães Resende, J; Maria Souza-Fagundes, E; Nascimento Cardoso, V; Odília Antunes Fernandes, S	1
Assous, MV; Ben-Chetrit, E; Bnaya, A; Tordgman, D; Wiener-Well, Y; Wolfovitz-Barchad, O; Yinnon, AM	1
Li, PD; Qu, PH; Zhang, DF; Zhang, ZF	1
Badia, X; Cantón, R; Del Pozo, JL; Ferrer, R; García-Vidal, C; Garnacho-Montero, J; Giró-Perafita, N; Larrosa, N; Pintado, V; Rascado, P; Salavert, M; Soriano, A	1
Al-Madboly, LA	1
Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR	1
Chen, L; Deng, Y; Huang, X; Yang, Y; Yu, H; Yue, M	1
Aysert-Yildiz, P; Dizbay, M; Habibi, H; Özgen-Top, Ö	1
Adnan, NA; Alagely, HS; Baqer, AA; Musa, M; Nor, NSM	1
Abdurahim, SA; Alameen, AA; Aloufi, AS; Elsayim, R; Eltayb, WA; Modafer, Y	1
Aiesh, BM; Maali, Y; Omarya, S; Qandeel, F; Sabateen, A; Sholi, S; Taha, AA; Taha, SA; Zyoud, SH	1
Kelsom, C; Lou, M; Nieberg, P; Sophonsri, A; Wong-Beringer, A	1
Bao, YX; Chen, FR; Gao, JY; Guo, HM; Ren, L; Wang, HW; Wang, KH; Xie, ZR; Xu, Y; Yang, B; Zhou, SY	1
Cano, Á; Castón, JJ; García-Gutiérrez, M; Gracia-Ahufinger, I; Guzmán-Puche, J; Marfil-Pérez, E; Martínez-Martínez, L; Natera, AM; Pérez-Nadales, E; Recio, M; Torre-Cisneros, J	1
Ahn, JY; Choi, H; Choi, JY; Choi, YH; Jeong, SJ; Kim, JM; Ku, NS; Lee, SH; Lim, YS; Shin, SJ; Song, YG; Yeom, JS; Yong, D	1
Barquist, L; Blaskovich, MAT; Boinett, CJ; Butler, MS; Cain, AK; Cooper, MA; Edwards, IA; Elliott, AG; Huang, JX; Lociuro, S; Lundberg, CV; Mobli, M; Neve, S; Porter, KM; Steen, J; Strandh, M; Zuegg, J	1
Avcı, O; Baltacı, S; Büyüktuna, SA; Çelik, C; Elaldı, N; Fırtına Topcu, K; Hasbek, M; Ünlüsavuran, M	1
Cerrato, SG; Medeiros, EA; Salles, TCG; Santana, TF	1
Ani Caovilla Follador, F; Carolina Lucio, L; Elize Defante Ferreto, L; Fiorentin Vandresen, D; Paula Vieira, A; Pereira Bento Casaril, K; Pitt Benedetti, V; Shigueyasu Yamada, R; Viviane Buzanello Martins, C; Welter Wendt, G	1
Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R	1
Chen, H; Huang, W; Jiang, Y; Liu, X; Ma, Y; Tan, X; Zhang, M; Zhao, Y	1
Chen, JW; Chia, JS; Chuang, YC; Hsu, CC; Huang, TY; Jung, CJ; Kuo, YM; Liao, YD	1
Chen, IR; Huang, PH; Lin, YT; Wang, FD; Wu, PF	1
Chen, C; Chen, YB; Wang, HB; Zhang, BL; Zhu, XY; Zhu, YH	1
Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD	1
Pilmis, B; Timsit, JF; Zahar, JR	1
Bassetti, M; Carnelutti, A; Peghin, M; Righi, E	1
Fisher, K; Juang, P; Kollef, MH; Micek, ST; Trupka, T	1
Carbo, J; Conway, EL; Kurtzhalts, K; Lin, K; Mergenhagen, KA; Ott, MC; Sellick, JA	1
Hauser, AR; Krapp, F; Morris, AR; Ozer, EA	1
Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Seok, H; Song, JH	1
Huang, D; Jacobs, DM; Minhaj, F; Parker, A; Rao, GG; Safir, MC	1
Al-Tawfiq, JA; Eljaaly, K; Enani, MA	1
Sakata, H	1
Li, J; Wang, Z; Zhao, D; Zuo, Y	1
Akkoyunlu, Y; Aslan, T; Daskaya, H; Durdu, B; Hakyemez, IN; Meric Koc, M; Sumbul Gultepe, B	1
Fu, Y; Ren, D; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J; Zhu, B	1
Kaniga, K; Lee, M; Redman, R; Rice, DA	1
Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY	1
Cao, X; Chen, R; Guan, H; Huang, XL; Pei, XF; Xu, X; Zhou, T	1
Karvouniaris, M; Makris, D; Manoulakas, E; Mantzarlis, K; Zakynthinos, E	1
Ouchi, K; Sunakawa, K	1
Lü, J; Wang, X; Zhang, R	1
Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M	1
Dong, F; Guo, L; Li, S; Liu, G; Liu, L	1
Kasahara, H; Kataoka, H; Matsumoto, M; Sasagawa, Y; Shimada, S	1
Camargo, CH; Costa, SF; de Maio Carrilho, CM; de Oliveira, LM; Gaudereto, J; Grion, CM; Levin, AS; Perozin, JS; Urbano, MR	1
Aslam, S; Kotton, CN; Kumar, D; Logan, C; Mehta, SR	1
Haruyama, S; Nakamura, M; Ohmori, S; Okada, E; Sawada, Y; Shibata, M; Yamaguchi, T; Yoshioka, M	1
Iwata, S; Kuroki, H; Ouchi, K; Sakata, H; Tajima, T	1
Mandell, L	1
Akhras, K; Caro, JJ; Kongnakorn, T; Merchant, S; Mwamburi, M; Nathwani, D	1
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM	1
De Waele, JJ; Lipman, J; Paterson, DL; Roberts, JA; Udy, AA	1
Hong, KW; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ	1
Bi, S; Fan, W; Huang, Y; Ji, Z; Li, L; Wiradharma, N; Xu, K; Yang, YY	1
Bernabeu-Wittel, M; García-Curiel, A; Jiménez-Mejías, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C	1
Hu, Y; Li, LQ; Yu, JL	1
Bradley, JS; Garau, J; Lode, H; Quinn, JP; Rolston, KV; Wilson, SE	1
Reed, RL	1

Reviews

10 review(s) available for carbapenems and Pneumonia

Article	Year
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Consensus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia; Respiratory System; Risk Factors	2022
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia	2020
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae? Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Pneumonia; Pneumonia, Ventilator-Associated; Risk Factors	2017
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? Seminars in respiratory and critical care medicine, 2017, Volume: 38, Issue:3 Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors	2017
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review. Annals of clinical microbiology and antimicrobials, 2017, Nov-25, Volume: 16, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Minocycline; Pneumonia; Polymyxin B; Polymyxins; Tigecycline; Treatment Outcome; Urinary Tract Infections	2017
Impact of carbapenem versus non-carbapenem treatment on the rates of superinfection: A meta-analysis of randomized controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:11 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia; Randomized Controlled Trials as Topic; Risk Factors; Superinfection; Treatment Outcome	2018
[Effect of new oral antimicrobial agents in outpatient treatment of pneumonia in children]. The Japanese journal of antibiotics, 2014, Volume: 67, Issue:3 Topics: Administration, Oral; Anti-Infective Agents; Carbapenems; Child; Fluoroquinolones; Humans; Naphthyridines; Outpatients; Pneumonia	2014
Doripenem: a new carbapenem in the treatment of nosocomial infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Carbapenems in clinical practice: a guide to their use in serious infection. International journal of antimicrobial agents, 1999, Volume: 11, Issue:2 Topics: Bacterial Infections; Carbapenems; Child; Drug Resistance, Microbial; Fever; Humans; Intensive Care Units; Meningitis, Bacterial; Neutropenia; Peritonitis; Pneumonia	1999
Antibiotic choices in surgical intensive care unit patients. The Surgical clinics of North America, 1991, Volume: 71, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Carbapenems; Cephalosporins; Critical Care; Drug Resistance, Microbial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monobactams; Mycoses; Penicillins; Pneumonia; Surgical Wound Infection; Vancomycin	1991

Trials

1 trial(s) available for carbapenems and Pneumonia

Article	Year
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials. International journal of antimicrobial agents, 2013, Volume: 41, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections	2013

Article

Year

Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.

International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013

Other Studies

50 other study(ies) available for carbapenems and Pneumonia

Article	Year
Pegylated LyeTx I-b peptide is effective against carbapenem-resistant Acinetobacter baumannii in an in vivo model of pneumonia and shows reduced toxicity. International journal of pharmaceutics, 2021, Nov-20, Volume: 609 Topics: Acinetobacter baumannii; Animals; Antimicrobial Cationic Peptides; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; HEK293 Cells; Humans; Mice; Microbial Sensitivity Tests; Peptide Fragments; Peptides; Pneumonia; Polyethylene Glycols; Receptors for Activated C Kinase	2021
Rate and Risk Factors for Carbapenem Resistant Acinetobacter baumannii Clinical Infections in Colonized Patients. The Israel Medical Association journal : IMAJ, 2022, Volume: 24, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Retrospective Studies; Risk Factors	2022
Characterization of carbapenem-resistant Acinetobacter baumannii ST540 and Klebsiella pneumoniae ST2237 isolates in a pneumonia case from China. Journal of applied microbiology, 2022, Volume: 133, Issue:3 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Pneumonia	2022
A Novel Triple Combination To Combat Serious Infections with Carbapenem-Resistant Acinetobacter baumannii in a Mouse Pneumonia Model. Microbiology spectrum, 2022, 10-26, Volume: 10, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Ascorbic Acid; Biological Factors; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Inflammation; Mice; Microbial Sensitivity Tests; Pneumonia; Transferrins	2022
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:5 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients	2022
Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia. BMC infectious diseases, 2022, Oct-21, Volume: 22, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Retrospective Studies; Sulbactam; Tigecycline	2022
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Journal of chemotherapy (Florence, Italy), 2023, Volume: 35, Issue:6 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections	2023
ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF KLEBSIELLA PNEUMONIA. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2023, Volume: 51, Issue:1 Topics: Bacteriophages; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Myoviridae; Pneumonia	2023
Molecular Dynamic Analysis of Carbapenem-Resistant Molecules (Basel, Switzerland), 2023, Mar-09, Volume: 28, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Humans; Imipenem; Klebsiella; Klebsiella pneumoniae; Ligands; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Monobactams; Nanoparticles; Pneumonia; Porins; Spectroscopy, Fourier Transform Infrared; Zinc Oxide	2023
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country. BMC infectious diseases, 2023, Oct-02, Volume: 23, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Developing Countries; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Retrospective Studies; Sulfamethoxazole; Tertiary Care Centers; Trimethoprim	2023
Risk factors and outcome associated with coinfection with carbapenem-resistant Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Coinfection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Pseudomonas aeruginosa; Risk Factors	2023
Draft genome sequence analysis of a high carbapenem-resistant Klebsiella quasipneumoniae subsp. quasipneumoniae strain isolated from an HIV-positive patient with pneumonia. Journal of global antimicrobial resistance, 2019, Volume: 19 Topics: Adult; Base Composition; Carbapenems; Coinfection; Drug Resistance, Multiple, Bacterial; Genome Size; Genome, Bacterial; High-Throughput Nucleotide Sequencing; HIV Infections; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Pneumonia; Whole Genome Sequencing	2019
In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia. Scientific reports, 2019, 11-20, Volume: 9, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline	2019
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria. Nature communications, 2020, 06-23, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Cell Membrane Permeability; Colistin; Disease Models, Animal; Drug Discovery; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Helminth Proteins; Humans; Male; Mice; Microbial Sensitivity Tests; Peritonitis; Pneumonia; Urinary Tract Infections	2020
[Klebsiella pneumoniae Infections in the Intensive Care Unit: Risk Factors Related to Carbapenem Resistance and Patient Mortality]. Mikrobiyoloji bulteni, 2020, Volume: 54, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Reproducibility of Results; Retrospective Studies; Risk Factors; Sheep	2020
Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates. PloS one, 2020, Volume: 15, Issue:11 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Mortality; Outpatients; Patient Admission; Pneumonia; Prevalence; Treatment Outcome; Urinary Tract Infections	2020
Associated factors of Acinetobacter baumannii complex in hospitalized patients: A case-control study. Journal of infection in developing countries, 2021, 01-31, Volume: 15, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Risk Factors; Young Adult	2021
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience. Microbial drug resistance (Larchmont, N.Y.), 2021, Volume: 27, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome	2021
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Frontiers in cellular and infection microbiology, 2021, Volume: 11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Lung; Male; Microbial Sensitivity Tests; Phage Therapy; Pneumonia; Pulmonary Disease, Chronic Obstructive	2021
Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia. Scientific reports, 2021, 04-01, Volume: 11, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Design; Drug Resistance, Multiple, Bacterial; Hemolysis; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Pneumonia; Pore Forming Cytotoxic Proteins; Stem Cells	2021
Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae. Journal of global antimicrobial resistance, 2021, Volume: 25 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Retrospective Studies; Taiwan	2021
Clinical characteristics and risk factors associated with secondary bloodstream infection in patients with intensive care unit-acquired pneumonia due to carbapenem-resistant Klebsiella pneumoniae. Chinese medical journal, 2021, Jul-20, Volume: 134, Issue:14 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia; Risk Factors	2021
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. BMC infectious diseases, 2017, Apr-17, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Health Care Costs; Hospital Mortality; Hospitalization; Humans; Inappropriate Prescribing; Length of Stay; Male; Middle Aged; Pneumonia; Prevalence; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Urinary Tract Infections	2017
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study. Critical care (London, England), 2017, 07-15, Volume: 21, Issue:1 Topics: Academic Medical Centers; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Cross-Over Studies; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Monobactams; Pneumonia; Pneumonia, Ventilator-Associated; Prospective Studies; Quinolones; Respiration, Artificial; Statistics, Nonparametric	2017
Impact of Penicillin Allergy on Time to First Dose of Antimicrobial Therapy and Clinical Outcomes. Clinical therapeutics, 2017, Volume: 39, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Hypersensitivity; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Middle Aged; Patient Readmission; Penicillins; Pneumonia; Retrospective Studies; Sepsis; Urinary Tract Infections	2017
Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains from Patients with Necrotizing Skin and Soft Tissue Infections. Scientific reports, 2017, 10-19, Volume: 7, Issue:1 Topics: Adult; Aged; Animals; Carbapenems; Drug Resistance, Bacterial; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred C57BL; Middle Aged; Phagocytosis; Pneumonia; Retrospective Studies; Skin Diseases; Soft Tissue Infections; Virulence	2017
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy. Annals of hematology, 2018, Volume: 97, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Pneumonia; Prognosis; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Clinical evaluation of 3-day tebipenem pivoxil therapy in children with community-acquired pneumonia. The Japanese journal of antibiotics, 2016, Volume: 69, Issue:3 Topics: Carbapenems; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Male; Pneumonia; Retrospective Studies; Time Factors	2016
Characterize carbapenem-resistant Klebsiella pneumoniae isolates for nosocomial pneumonia and their Gram-negative bacteria neighbors in the respiratory tract. Molecular biology reports, 2019, Volume: 46, Issue:1 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Pneumonia; Respiratory System; Retrospective Studies	2019
Risk Factors Affecting Patterns of Antibiotic Resistance and Treatment Efficacy in Extreme Drug Resistance in Intensive Care Unit-Acquired Klebsiella Pneumoniae Infections: A 5-Year Analysis. Medical science monitor : international medical journal of experimental and clinical research, 2019, Jan-07, Volume: 25 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Survival Rate; Tigecycline; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2019
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital. Medicine, 2019, Volume: 98, Issue:13 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Catheter-Related Infections; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; Mortality; Pneumonia; Retrospective Studies; Risk Factors	2019
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia. American journal of infection control, 2013, Volume: 41, Issue:7 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors	2013
[A study on carbapenem resistance in klebsiella pneumoniae]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2013, Volume: 44, Issue:2 Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia	2013
Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study. BioMed research international, 2013, Volume: 2013 Topics: Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Prospective Studies; Risk Factors	2013
[Isolation of a carbapenem-resistant K1 serotype Klebsiella pneumonia strain and the study of resistance mechanism]. Zhonghua yi xue za zhi, 2014, Dec-16, Volume: 94, Issue:46 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Pneumonia; Virulence	2014
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013]. Zhonghua yi xue za zhi, 2015, Jun-09, Volume: 95, Issue:22 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin	2015
[Clinical features and antibiotic resistance of Escherichia coli bloodstream infections in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2016, Volume: 54, Issue:2 Topics: Adolescent; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections	2016
[Evaluation of safety and efficacy of tebipenem pivoxil granules for pediatric in pneumonia, otitis media and sinusitis]. The Japanese journal of antibiotics, 2016, Volume: 69, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Pneumonia; Product Surveillance, Postmarketing; Sinusitis	2016
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC infectious diseases, 2016, Nov-03, Volume: 16, Issue:1 Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Polymerase Chain Reaction; Prospective Studies; Renal Dialysis; Risk Factors; Shock, Septic; Urinary Tract Infections	2016
Use of organs from donors with bloodstream infection, pneumonia, and influenza: Results of a survey of infectious diseases practitioners. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Candidemia; Carbapenems; Clinical Decision-Making; Cross Infection; Donor Selection; Drug Resistance, Bacterial; Humans; Influenza, Human; Pneumonia; Practice Guidelines as Topic; Surveys and Questionnaires; Tissue Donors; Transplants	2017
Maculopapular eruption caused by doripenem. European journal of dermatology : EJD, 2017, 04-01, Volume: 27, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Eruptions; Exanthema; Humans; Male; Middle Aged; Pneumonia	2017
Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; C-Reactive Protein; Carbapenems; Child; Child, Preschool; Community-Acquired Infections; Female; Humans; Infant; Male; Pneumonia	2017
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation. Current medical research and opinion, 2010, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Humans; Pneumonia; United States	2010
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins	2011
What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Doripenem; Humans; Kidney; Metabolic Clearance Rate; Pneumonia; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic	2012
Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. Journal of Korean medical science, 2012, Volume: 27, Issue:5 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Age Factors; Aged; Anti-Bacterial Agents; APACHE; Carbapenems; Diabetes Complications; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Odds Ratio; Pneumonia; Prognosis; Retrospective Studies; Risk Factors; Shock, Septic; Survival Rate	2012
Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection. Biomaterials, 2012, Volume: 33, Issue:34 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Drug Resistance, Bacterial; Humans; Lethal Dose 50; Lung; Male; Mice; Peritoneum; Peritonitis; Pneumonia; Structure-Activity Relationship	2012
Morphological changes induced by imipenem and meropenem at sub-inhibitory concentrations in Acinetobacter baumannii. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10 Topics: Acinetobacter baumannii; Carbapenems; Cross Infection; Histocytochemistry; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pneumonia; Thienamycins	2004
[Clinical value and multiple risk factors analysis of sputum culture for fungus in neonates]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2007, Volume: 45, Issue:6 Topics: Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Child; Clinical Laboratory Techniques; Fungi; Humans; Incidence; Infant; Infant, Newborn; Mycoses; Pneumonia; Risk Factors; Sputum	2007
Doripenem (doribax)--a new parenteral carbapenem. Obstetrics and gynecology, 2008, Volume: 111, Issue:5 Topics: Carbapenems; Cross Infection; Doripenem; Female; Humans; Pneumonia; Pneumonia, Ventilator-Associated; Urinary Tract Infections	2008